Need to screen for Chagas disease and Strongyloides infestation in non-endemic countries prior to treatment with biologics.
Servicio de Dermatología, Hospital Universitario La Paz, Madrid, España. Electronic address: gnzalezramosjessica@gmail.com.
J
J
González-Ramos
Servicio de Dermatología, Hospital Universitario La Paz, Madrid, España.
M L
ML
Alonso-Pacheco
Unidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital Universitario La Paz, Madrid, España.
M
M
Mora-Rillo
Servicio de Dermatología, Hospital Universitario La Paz, Madrid, España.
P
P
Herranz-Pinto
D000799:Angioedema / Q000150:complications; D000818:Animals; D000909:Antibodies, Helminth / Q000097:blood; D000913:Antibodies, Protozoan / Q000097:blood; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000150:complications / Q000188:drug therapy; D001838:Bolivia / Q000208:ethnology; D014355:Chagas Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D004198:Disease Susceptibility; D057915:Drug Substitution; D019353:Endemic Diseases; D000068800:Etanercept / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007559:Ivermectin / Q000627:therapeutic use; D009593:Nitroimidazoles / Q000627:therapeutic use; D018579:Patient Selection; D013030:Spain; D013322:Strongyloidiasis / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology
D000909:Antibodies, Helminth; D000913:Antibodies, Protozoan; D000981:Antiprotozoal Agents; D018501:Antirheumatic Agents; D009593:Nitroimidazoles; D007559:Ivermectin; D000068800:Etanercept; C009999:benzonidazole